Premier Anesthesia, a leading, privately held anesthesia practice management firm, has announced a new partnership with City of Hope Phoenix Cancer Center, marking its expansion into the Arizona healthcare market and enhancing its commitment to comprehensive cancer care.
City of Hope Phoenix Cancer Center is a nationally accredited oncology institution committed to delivering patient-centered care and is renowned for its advanced therapies for blood cancer, including leukemia, myeloma and rare hematologic conditions. The center also manages one of the nation’s largest and most successful bone marrow transplant programs. Through this partnership, Premier Anesthesia will provide operational and clinical support, serving a key role in City of Hope’s planned expansion through 2026.
“Expanding access to high‑quality cancer services requires strong clinical partners aligned in mission and values,” said Dr. Alan H. Bryce, medical oncologist and chief clinical officer at City of Hope Phoenix Cancer Center. “This collaboration strengthens our ability to deliver compassionate, evidence‑based care and research to more patients in Arizona and to do it closer to home as we work together to improve outcomes for all Arizonans.”
“Our partnership represents an important step beyond geographic expansion by reinforcing shared values in mission, culture and patient care,” added Preston Smith, president of Premier Anesthesia. “City of Hope maintains a strong focus on the patient experience throughout all stages of care, a principle that is integral to Premier’s anesthesia services. We are honored to contribute to City of Hope’s vision and support its sustained growth in Arizona.”
Together, Premier Anesthesia and City of Hope are committed to providing compassionate, high-quality care. Their partnership is designed to help ensure anesthesia services enhance both clinical excellence and the overall patient experience as cancer care continues to evolve in Arizona.
